Reduced-Dose Schedule of Prophylaxis Based on Local Data Provides Near-Optimal Protection Against Respiratory Syncytial Virus (Q30938699)

11 August 2017

Reduced-Dose Schedule of Prophylaxis Based on Local Data Provides Near-Optimal Protection Against Respiratory Syncytial Virus (English)

1 reference

11 August 2017

5

Cécile Viboud

1 reference

11 August 2017

Virginia E Pitzer

6

0 references

Daniel M Weinberger

object named as

Daniel M Weinberger

series ordinal

1

0 references

Vivek Charu

series ordinal

4

object named as

Vivek Charu

1 reference

11 August 2017

3

Claudia A Steiner

1 reference

11 August 2017

Joshua L Warren

2

1 reference

PMCID

4542596

11 August 2017

language of work or name

English

0 references

publication date

22 April 2015

1 reference

Clinical Infectious Diseases

11 August 2017

1 reference

11 August 2017

61

1 reference

11 August 2017

4

1 reference

11 August 2017

506-514

1 reference

Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Respiratory syncytial virus surveillance in the United States, 2007-2012: results from a national surveillance system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Risk factors and outcomes for respiratory syncytial virus-related infections in immunocompromised children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

A review of cost-effectiveness of palivizumab for respiratory syncytial virus.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Predictors of the duration of the respiratory syncytial virus season

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

An every other year cyclic epidemic of infants hospitalized with respiratory syncytial virus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Variation in timing of respiratory syncytial virus outbreaks: lessons from national surveillance

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FCID%2FCIV331

Substantial variability in community respiratory syncytial virus season timing

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FCID%2FCIV331

Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FCID%2FCIV331

Respiratory syncytial virus--United States, July 2007-June 2011.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Seroprevalence of anti-RSV IgG in Thai children aged 6 months to 5 years.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542596

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

25 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25904370

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cost-effectiveness analysis of palivizumab among pre-term infant populations covered by Medicaid in the United States

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25904370

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/CID/CIV331

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

PMCID

4542596